Foreign Institutional Investors (FIIs) increasing their holding stake in certain companies indicate a positive outlook on the company’s performance, management, and prospects, thereby leading to speculation of expected future growth and upcoming changes in the company.
Listed Below are some of the Financially strong and well-known stocks in which Foreign Institutional Investors have consistently increased their holding in the last four Quarters.
KFin Technologies
KFin Technologies Limited is a leading technology-driven financial services platform, it provides services and solutions to asset managers and corporate issuers across asset classes in India and provides several investor solutions including transaction origination and processing for mutual funds, private retirement schemes, and others.
With a market capitalization of Rs. 17,782 Crores, the shares of KFin Technologies Limited closed at Rs. 1,037.75 per equity share, up 0.31 percent from its previous day’s close price of Rs. 1,034.50.
Foreign Institutional Investors have consistently increased their holding in KFin Technologies Limited in the last 4 quarters from 9.22 percent in Q2FY24 to 22.80 percent in Q1FY25.
Its revenue from operations grew by 30.89 percent from Rs. 182 Crores in Q1FY24 to Rs. 238 Crores in Q1FY25, accompanied by profits of Rs. 43 Crores to Rs. 68 Crores.
Also Read
Kaynes Technology India
Kaynes Technologies India Limited is an end-to-end and Internet of Things (IoT) solutions-enabled integrated electronics manufacturer.It offers Solutions for Box Build, Printed Circuit Board Assemblies (PCBAs), ODM, Product Engineering, loT Solutions, smart metering technology, smart street lighting, and inverter technology. It also offers conceptual design and product engineering services.
With a market capitalization of Rs. 30,338 Crores, the shares of Kaynes Technology India Limited closed at Rs. 4,746 per equity share, down 0.11 percent from its previous day’s close price of Rs. 4,751.80.
Foreign Institutional Investors have consistently increased their holding in Kaynes Technology India Limited in the last 4 quarters from 9.90 percent in Q2FY24 to 14.27 percent in Q1FY25.
Its revenue from operations grew by 70 percent from Rs. 297 Crores in Q1FY24 to Rs. 504 Crores in Q1FY25, accompanied by profits of Rs. 25 Crores to Rs. 51 Crores.
Suzlon Energy
Suzlon Energy Limited is one of the leading renewable energy solutions providers in the world engaged in the generation of renewable energy and providing full-stack solutions related to it like designing, manufacturing, project execution, operation, and maintenance of wind turbine generators and sale of related components.
With a market capitalization of Rs. 1,03,431 Crores, the shares of Suzlon Energy Limited closed at Rs. 75.83 per equity share, down 1.5 percent from its previous day’s close price of Rs. 76.98.
Foreign Institutional Investors have consistently increased their holding in Suzlon Energy Limited in the last 4 quarters from 10.88 percent in Q2FY24 to 21.53 percent in Q1FY25.
Its revenue from operations grew by 49.64 percent from Rs. 1,351 Crores in Q1FY24 to Rs. 2,022 Crores in Q1FY25, accompanied by profits of Rs. 101 Crores to Rs. 302 Crores.
Gravita India
Gravita India Limited is engaged in operations of specialized verticals like Lead Recycling(flagship), Aluminum recycling, Plastic recycling, and Turnkey projects with a healthy order book of 60,000 MT+.
With a market capitalization of Rs. 15,698 Crores, the shares of Gravita India Limited closed at Rs. 2,273.70 per equity share, up 5.56 percent from its previous day’s close price of Rs. 2,153.95.
Foreign Institutional Investors have consistently increased their holding in Gravita India Limited in the last 4 quarters from 9.99 percent in Q2FY24 to 13.40 percent in Q1FY25.
Its revenue from operations grew by 29.07 percent from Rs. 703 Crores in Q1FY24 to Rs. 908 Crores in Q1FY25, accompanied by profits of Rs. 53 Crores to Rs. 68 Crores.
Marksans Pharma Limited is engaged in the business of research, manufacture, marketing, and sale of pharmaceutical formulations across various therapeutic areas, such as pain management, cough and cold, cardiovascular, central nervous system, and many more.
With a market capitalization of Rs. 99,680 Crores, the shares of Mankind Pharma Limited closed at Rs. 2,488 per equity share, up 2.59 percent from its previous day’s close price of Rs. 2,425.25.
Foreign Institutional Investors have consistently increased their holding in Genus Power Infrastructures Limited in the last 4 quarters from 4.18 percent in Q2FY24 to 11.58 percent in Q1FY25.
Its revenue from operations grew by 14.86 percent from Rs. 2,092 Crores in Q1FY24 to Rs. 2,403 Crores in Q1FY25, accompanied by profits of Rs. 409 Crores to Rs. 513 Crores.
Written by: Bharath K.S
Also Read
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
